Abstract:Objective To study the changes in levels of interleukin (IL)-6, IL-10, tumor necrosis factor-alpha (TNF-α), and alkaline phosphatase (ALP) in the gingival crevicular fluid (GCF) of patients with severe chronic periodontitis before and after nonsurgical periodontal therapy and to explore the relationship among the levels of these four biomarkers in GCF, their periodontal status and their clinical significance to evaluate the effect of nonsurgical periodontal therapy and periodontitis activity. Methods In total, 30 patients with severe chronic periodontitis were enrolled in a 1-year longitudinal pilot study (Chinese Clinical Trial Registry: ChiCTR-OCH-13004679). At baseline and 1, 3, 6, and 12 months after nonsurgical therapy, the periodontal clinical indicators plaque index (PLI), probing depth (PD), clinical attachment loss (CAL), sulcus bleeding index (SBI) were recorded. Filter paper strips were used to collect two deep-pocket (probing depth ≥ 6 mm) and two shallow-pocket (probing depth ≤ 4 mm) periodontal sites for each patient and weighed. The levels of interleukin IL-6, IL-10, TNF-α, and ALP in GCF were assessed using enzyme-linked immunosorbent assay. Meanwhile, 30 healthy sites of 15 subjects with healthy periodontium were used as the baseline controls for patients with severe chronic periodontitis. Results At the baseline, the TNF-α, ALP and IL-6 levels in GCF of the disease sites of patients with periodontitis were significantly higher than those in healthy periodontal sites of the control group (P < 0.001), and the levels of IL-10 were significantly lower than those in the control group (P < 0.001). In patients with severe chronic periodontitis, the levels of TNF-α, ALP and IL-6 in GCF at deep-pocket sites were significantly higher than those at shallow-pocket sites (P <0.001), and the IL-10 levels were significantly lower than those at shallow-pocket sites (P < 0.001). 1, 3, 6, and 12 months after nonsurgical treatment, the levels of TNF-α and ALP in GCF at the shallow- and deep-pocket sites in patients with chronic periodontitis significantly decreased, the level of IL-10 significantly increased (P < 0.005), and the level of IL-6 in GCF at the deep-pocket sites significantly decreased (P < 0.005). However, there was no significant difference in IL-6 level at shallow-pocket sites (P > 0.05). 1, 3, 6, and 12 months after nonsurgical treatment, the periodontal clinical indicators were improved compared with the baseline. In addition, there was a significant correlation between the levels of these four biomarkers and the periodontal clinical parameters (P < 0.05). During the two follow-up visits after nonsurgical periodontal therapy, the sites with more than 2-mm increase in attachment loss had significant differences in the levels of the four biomarkers in the GCF compared with the previous visit time (P < 0.005). Conclusion The detection of the levels of these four biomarkers in GCF has strong clinical significance for assessing the severity of periodontitis and the efficacy of nonsurgical periodontal therapy. Increased levels of TNF-α, ALP, and IL-6 and decreased IL-10 levels in GCF may indicate periodontitis progression at this site.

Quantitative Analysis of Serum TGF-β Isoforms in Chronic Periodontitis Patients

Testing of Periodontal Clinical Indicators and Serum TNF-α Level in Periodontal Patients with Coronary Heart Disease

Cytokine Levels in Plasma and Gingival Crevicular Fluid in Chronic Periodontitis.

The Effect of Chronic Periodontitis on Serum Levels of Matrix Metalloproteinase-2 (Mmp-2), Tissue Inhibitor of Metalloproteinase-1 (Timp-1), Interleukin-12 (Il-12) and Granulocyte-Macrophage Colony-Stimulating Factor (Gm-Csf)

[Interleukin-1Beta and IL-1 Receptor Antagonist Levels in Gingival Crevicular Fluid and Their Relationship to Clinical Indices of Periodontitis].

Proteomic and single-cell analysis shed new light on the anti-inflammatory role of interferonβ in chronic periodontitis

Biomarker Levels in Gingival Crevicular Fluid of Subjects with Different Periodontal Conditions: A Cross-Sectional Study

[Levels of Interleukin-1Beta and Tumor Necrosis Factor-Alpha in Patients with Aggressive Periodontitis].

Quantification of tryptase and TIM-3 double positive mast cells in human chronic periodontitis tissue

Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients

Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue

Effect of Transforming Growth Factor-β1 on the Levels of IL-6 and BGP in Periodontal Tissues in Rats

[Changes of Circulating IFN-gamma, IL-4 in Patients with Chronic Periodontitis Before and after Periodontal Initial Therapy].

Systemic inflammatory burden and local inflammation in periodontitis: What is the link between inflammatory biomarkers in serum and gingival crevicular fluid?

Changes and clinical significance of four biomarkers in gingival crevicular fluid after nonsurgical periodontal therapy

The Interplay of Lipopolysaccharide-Binding Protein and Cytokines in Periodontal Health and Disease.

Proteomic Analysis Of Saliva Obtained From Patients With Chronic Periodontitis

Human β-defensins are correlated with the immune infiltration and regulated by vitamin D3 in periodontitis

Interleukin-11, interleukin-1beta, interleukin-12 and the pathogenesis of inflammatory periodontal diseases

Changes of Oral Flora, Inflammatory Factors, and Immune Function Indicators in Patients with Chronic Periodontitis and Their Clinical Significance

Effect of treatment of chronic periodontitis on level of serum inflammatory markers in elderly patients